SouthState’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.99K Hold
9
– – ﹤0.01% 977
2026
Q2
$1.75K Sell
9
-9
-50% -$1.86K ﹤0.01% 976
2026
Q1
$4.04K Hold
18
– – ﹤0.01% 787
2025
Q4
$4.34K Sell
18
-2
-10% -$511 ﹤0.01% 831
2025
Q3
$5.48K Sell
20
-47
-70% -$12.8K ﹤0.01% 749
2025
Q2
$17.3K Sell
67
-17
-20% -$4.06K ﹤0.01% 684
2025
Q1
$18.8K Buy
+84
New +$19.6K ﹤0.01% 704
2024
Q3
– Sell
-13
Closed -$2.49K – 638
2024
Q2
$2.49K Sell
13
-278
-96% -$56.4K ﹤0.01% 583
2024
Q1
$57.6K Buy
+291
New +$53.3K ﹤0.01% 360

Other funds holding RMD

SouthState's RMD Position: Q3 2026 in Review

SouthState held its ResMed (RMD) position steady in Q3 2026 at 9 shares worth $1.99K. The position accounts for ﹤0.01% of the portfolio, ranked #977.

SouthState first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $57.6K in Q1 2024. 749 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • SouthState held 9 shares of ResMed worth $1.99K as of Q3 2026.
  • SouthState left its ResMed share count unchanged in Q3 2026.
  • ResMed made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #977 holding.
  • SouthState first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
  • SouthState's ResMed position peaked at $57.6K in Q1 2024.
  • 749 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.